Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Register now for exclusive savings and additional group discounts: URLs: Tickets: Brochure: Prices: Drug Developer Pricing | Conference Only: USD 2999.00, Academic Pricing | Conference Only : USD 2599.00, Standard Pricing | Conference Only: USD 3699.00 Speakers: Andrew Young - Chief Medical Officer - i2o Therapeutics, Eduardo Santos - Executive Director and Head of General Medicines, Therapeutic Areas, and Business Development | Global Value, Access, and Pricing - Amgen, Feng Liu - Executive Director | Research and Development - Regor Therapeutics, Ibrahim Turfanda - Senior Director | Next Generation Incretins | NILEX and Outcomes - Eli Lilly, Jo Bednarik - Executive Director | Medical Development, Diabetes, and Obesity - Eli Lilly, Jonathan Douros - Associate Director | Biology and Pharmacology - Novo Nordisk, Lars Johansson - Chief Scientific Officer - Antaros Medical, Leilani Morales - Global Chapter Lead | Medical Development and Evidence Generation - Roche, Maggie Kelleher - Senior Director/Team Lead | Commercial Strategy and Innovation Business Assessment | Internal Medicine and Digital - Pfizer, Manu Chakravarthy - Chief Scientific and Medical Officer - Carmot Therapeutics, Matthew Coghlan - Vice President and Head Incretin Portfolio Science - Eli Lilly, Paul Rubin - Chief Medical Officer - BioAge Labs, Scott Harris - Chief Medical Officer - Altimmune, Seulki Lee - Chief Executive Officer | D and D Pharmatech, Todd Hobbs - Chief Medical Officer - Diasome Pharmaceuticals Have a Question About this Festival
Heres the truth: GLP-1s may help in the long run, but CPAP therapy remains the proven, effective solution for treating sleep apnea today
"We need more data on the long-term effects and other outcomes related to cardiovascular health, particularly in lower-risk individuals," says Eva Madrid, co-lead researcher from the Universidad de Valparaso, Chile
This is where compounding pharmacies come in
The practical choices break down into two distinct routines: The Daily Tablet Routine: Oral semaglutide tablets require a strict morning schedule
This may impair bone formation and increase fracture risk
